ACTRN12618000778280已完成3 期
Restoring Microcirculatory Perfusion in ST-Elevation Myocardial Infarction (STEMI): A randomised trial to evaluate the efficacy of low-dose intracoronary tenecteplase in STEMI patients with high microvascular resistance post-percutaneous coronary intervention (PCI).
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •1) Adult men and women aged over 18 who present with STEMI within 12 hours of symptom onset. Patients will be eligible if they have symptoms consistent with myocardial ischaemia (chest pain, dyspnoea) for at least 20 minutes accompanied by definite ECGs indicating STEMI as defined by Australian NHF guidelines;
- •2) Willing and able to comply with all study requirements, including treatment, assessment and clinic visit attendances;
- •3) Able to personally read and understand the Participant Information and Consent Form and provide written, signed and dated informed consent to participate in the study.
- •4) (At time of PCI) Patient has received metallic drug-eluting stent
排除标准
- •At the time of screening or prior to randomisation, no known:
- •1) Previous coronary bypass grafting
- •2) Patients with other residual lesions with >50% diameter stenosis in the culprit vessel
- •3) Patients with prior myocardial infarction in the target territory
- •4) Presence of contraindications to thrombolytic therapy (including history of stroke and recent brain surgery active internal bleeding; history of cerebrovascular accident; intracranial or intraspinal surgery, or trauma within 2 months; intracranial neoplasm, arteriovenous malformation, or aneurysm; known bleeding diathesis; and severe uncontrolled hypertension)
- •5) Presence of contraindications to adenosine infusion for IMR measurement including sinus node disease, moderate to severe bronchoconstrictive disease and second or third-degree AV block
- •6) Concurrent illness, including severe infection that may jeopardise the ability of the patient to undergo the procedures outlined in this protocol with reasonable safety
- •7) Serious medical or psychiatric conditions that might limit the ability of the patient to comply with the protocol
- •8) Pregnancy, lactation, or inadequate contraception. Women must be post-menopausal, infertile, or use a reliable means of contraception. Women of childbearing potential must have a negative pregnancy test done within 7 days prior to registration. Men must have been surgically sterilised or use a (double if required) barrier method of contraception.
- •9) (Imaging (CMR) substudy only) Presence of contraindications to contrast enhanced MRI including pacemakers, metallic prostheses and estimated glomerular filtration rate of <30mL/min.
- •10) (At time of PCI) Patients who do not undergo primary PCI due to lack of severity of culprit lesion or other reasons.
研究者
相似试验
已完成
不适用
Preservation of microcirculatory perfusion after pulsatile cardiopulmonary bypass: the role of prothrombogenic processes and the endothelium.NL-OMON36700Vrije Universiteit Medisch Centrum48
招募中
不适用
The role of high power ultrasound in restoring blood flow for patients presenting with a major heart attack.Ischaemic Heart DiseaseST Elevation Myocardial InfarctionCoronary Microvascular DysfunctionMicrovascular ObstructionCardiovascular - Coronary heart diseaseCardiovascular - Other cardiovascular diseasesHeart FailureACTRN12620000807954niversity of Sydney150
已完成
不适用
Microvascular Function in Non-ST-segment Elevation Acute Coronary Syndromemicrovascular dysfunction1001108210003216NSTEMINL-OMON42844Academisch Medisch Centrum60
进行中（未招募）
不适用
Improve the myocardial reperfusion in ST elevation myocardial infarction: a randomized study between thrombectomy and pharmacological approach guided by the angiographic evidence of thrombusST elevation myocardial infarctionMedDRA version: 17.1Level: LLTClassification code 10064345Term: ST segment elevation myocardial infarctionSystem Organ Class: 100000004849EUCTR2014-005369-64-ESConsorci MAr Parc de Salut de Barcelona
已完成
不适用
Pulsatile II study.coronary artery bypass graft surgery, pulsatile cardiopulmonary bypass, microcirculatory perfusion, endothelial function, platelet aggregation, fibrinolysisNL-OMON21204VU Medisch Centrum; Amsterdam48